Core Viewpoint - Jindalai (688057) experienced a significant stock price increase, opening up by 8.79% and reaching a peak increase of over 11% on December 22, 2023, following announcements of capital increases in two medical technology companies [1] Group 1: Company Actions - Jindalai announced plans to invest 280 million yuan in Yunnan Jici Medical Technology Co., Ltd., acquiring a 34% stake in the company [1] - The company also plans to invest 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd., resulting in a 10% ownership stake [1] Group 2: Business Focus of Invested Companies - Yunnan Jici Medical focuses on the research and application of autologous cell technology [1] - Beijing Zhongke Hongtai specializes in the research, production, and sales of medical robotics technology and systems [1]

Core Viewpoint - Jindalai (688057) plans to invest 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd., acquiring a 10% stake, indicating a strategic move towards the medical robotics sector [1] Group 1: Investment Details - The investment amount is 30 million yuan, which will be used to increase the capital of Zhongke Hongtai [1] - After the transaction, Jindalai will hold a 10% equity stake in Zhongke Hongtai [1] Group 2: Company Strategy - Jindalai expresses optimism about the development prospects of medical robotics technology and systems, which are part of the national strategic emerging industries [1] - The company aims to gradually optimize its industrial structure and seek new opportunities for future growth, enhancing its risk resistance and cultivating new profit growth points [1]